Prevention of Perioperative Acute Renal Failure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-06-30

Study Completion Date

2011-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to measure the acute renal dysfunction on the first, second, seventh and twentieth days.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acute Post-cardiac Surgery Renal Failure: Prevention Through Individualized Intensive Hemodynamic Management

NCT04005105

Acute Kidney Injury

COMPLETED NA

Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients

NCT02499185

Acute Kidney Injury Arterial Hypertension Obesity +4 more

TERMINATED PHASE4

Preop Hemodialysis or Intraop Ultrafiltration for Patients With Severe Renal Dysfunction Undergoing Open Heart Surgery

NCT00720967

Non-Dialysis Dependent Severe Renal Dysfunction Cardiovascular Disease

UNKNOWN PHASE3

Identification of Preoperative Parameters to Predict Acute Kidney Injury Risk Following Vascular or Digestive Surgery

NCT05660174

Acute Kidney Injury

COMPLETED

Preoperative Nutritional Status and Postoperative Acute Kidney Injury

NCT05945940

Postoperative Acute Kidney Injury

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominal Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Isotonic saline

Group Type EXPERIMENTAL

Isotonic saline

Intervention Type DRUG

Isotonic saline administrated i.v at 1.5 ml/Kg/h , 8 to 12 h before surgery

No treatment

Habitual therapy

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Isotonic saline

Isotonic saline administrated i.v at 1.5 ml/Kg/h , 8 to 12 h before surgery

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who are undergoing elective abdominal surgery after appropriate information of the study, and its possible risks that may arise therefrom and that at any time to refuse their cooperation, give a written consent to participate in the study.
* Patients who at the time of the interview have an ASA between 2 and 4.
* Patients with chronic kidney failure mild moderate (serum creatinine between 1.5 and 3.0 mg / dl) can be included.

Exclusion Criteria

* Chronic kidney diseases with serum creatinine higher than 3.0 mg /DL
* Laparoscopic abdominal surgery
* ASA 1 and ASA 5 patients.
* Patients with cardiac insufficiency, ascites and respiratory insufficiency
* Diastolic hypertension \> 100 mmHg

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No